BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23074432)

  • 1. Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis.
    Thabane M;
    Ont Health Technol Assess Ser; 2012; 12(4):1-50. PubMed ID: 23074432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of smoking cessation and the implications for COPD.
    Faulkner MA; Lenz TL; Stading JA
    Int J Chron Obstruct Pulmon Dis; 2006; 1(3):279-87. PubMed ID: 18046865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.
    Atsou K; Chouaid C; Hejblum G
    PLoS One; 2011; 6(9):e24870. PubMed ID: 21949774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review.
    Sehatzadeh S
    Ont Health Technol Assess Ser; 2012; 12(3):1-64. PubMed ID: 23074431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention.
    Andreas S; Hering T; Mühlig S; Nowak D; Raupach T; Worth H
    Dtsch Arztebl Int; 2009 Apr; 106(16):276-82. PubMed ID: 19547629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease (COPD) evidentiary framework.
    OHTAC COPD Collaborative
    Ont Health Technol Assess Ser; 2012; 12(2):1-97. PubMed ID: 23074430
    [No Abstract]   [Full Text] [Related]  

  • 7. Should general practitioners screen smokers for COPD?
    Smith-Sivertsen T; Rortveit G
    Scand J Prim Health Care; 2004 Dec; 22(4):196-201. PubMed ID: 15765633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis.
    COPD Working Group
    Ont Health Technol Assess Ser; 2012; 12(7):1-64. PubMed ID: 23074435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease.
    Lock K; Wilson K; Murphy D; Riesco JA
    Expert Opin Pharmacother; 2011 Dec; 12(17):2613-26. PubMed ID: 22017336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands.
    Tsiachristas A; Burgers L; Rutten-van Mölken MP
    Value Health; 2015 Dec; 18(8):977-86. PubMed ID: 26686781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing and treating COPD.
    Dolan PL
    Med Econ; 2014 Mar; 91(5):54-8. PubMed ID: 25137911
    [No Abstract]   [Full Text] [Related]  

  • 12. Noninvasive positive pressure ventilation for acute respiratory failure patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis.
    McCurdy BR
    Ont Health Technol Assess Ser; 2012; 12(8):1-102. PubMed ID: 23074436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of an intensive smoking cessation intervention for COPD outpatients.
    Christenhusz LC; Prenger R; Pieterse ME; Seydel ER; van der Palen J
    Nicotine Tob Res; 2012 Jun; 14(6):657-63. PubMed ID: 22180589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective.
    Cedillo S; Sicras-Mainar A; Jiménez-Ruiz CA; Fernández de Bobadilla J; Rejas-Gutiérrez J
    Eur Addict Res; 2017; 23(1):7-18. PubMed ID: 27794567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPD and smoking cessation motivation.
    Kaminsky DA; Marcy TW
    Chest; 2004 May; 125(5):1958; author reply 1958-9. PubMed ID: 15136415
    [No Abstract]   [Full Text] [Related]  

  • 16. [Success of smoking cessation in patients with chronic obstructive pulmonary disease].
    Aytemur Solak Z; Başoğlu OK; Erdinç E
    Tuberk Toraks; 2006; 54(1):43-50. PubMed ID: 16615017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using PICO Methodology to Answer Questions About Smoking in COPD Patients.
    Jiménez Ruiz CA; Buljubasich D; Riesco Miranda JA; Acuña Izcaray A; de Granda Orive JI; Chatkin JM; Zabert G; Guerreros Benavides A; Paez Espinel N; Noé V; Sánchez-Angarita E; Núñez-Sánchez I; Sansores RH; Casas A; Palomar Lever A; Alfageme Michavila I
    Arch Bronconeumol; 2017 Nov; 53(11):622-628. PubMed ID: 28558926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease part 1: smoking cessation.
    Jones D
    Nurs Stand; 2015 Apr; 29(33):52-7. PubMed ID: 25872852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of quality and cost-effectiveness derived from Markov models evaluating smoking cessation interventions in patients with chronic obstructive pulmonary disease.
    Kirsch F
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):301-16. PubMed ID: 25600470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease modification in chronic obstructive pulmonary disease.
    Anzueto A
    Clin Chest Med; 2007 Sep; 28(3):609-16,vii. PubMed ID: 17720047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.